Stimuli-responsive liposomes for drug delivery

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 9, Issue 5, 2017, Pages

  Lee, Y ^a   Thompson, D H ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DRUG INTERACTIONS; DRUG PRODUCTS; ENZYME ACTIVITY; LIPOSOMES; NANOPARTICLES; PHOTOCHEMICAL REACTIONS;

ACTIVE PHARMACEUTICAL INGREDIENTS; DRUG DELIVERY STRATEGIES; ENHANCED PERMEATION AND RETENTIONS; INORGANIC NANOPARTICLE; MEMBRANE DESTABILIZATION; PHOTOCHEMICAL MECHANISM; STIMULI-RESPONSIVE SYSTEMS; TUMOR MICROENVIRONMENT;

REDOX REACTIONS;

ASPARTIC ACID; BICARBONATE; ESTER DERIVATIVE; GLUTARIC ACID; LIPID; NANOPARTICLE; OLEIC ACID; OXIME; POLYACRYLIC ACID; POLYMER; SUCCINIC ACID DERIVATIVE; DRUG CARRIER; LIPOSOME;

BILAYER MEMBRANE; CONTROLLED DRUG RELEASE; ENZYME ACTIVITY; HEAT; HUMAN; HYDROLYSIS; LIGHT; LIPOSOMAL DELIVERY; MEMBRANE STABILIZATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PH; PHOTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; STIMULUS RESPONSE; TUMOR MICROENVIRONMENT; CHEMISTRY; DRUG RELEASE; NEOPLASM;

DRUG CARRIERS; DRUG LIBERATION; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; NANOPARTICLES; NEOPLASMS; OXIDATION-REDUCTION; PHOTOCHEMICAL PROCESSES; POLYMERS; TUMOR MICROENVIRONMENT;

EID: 85013630412     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1450     Document Type: Review

References (195)

1. Zhu L, Torchilin VP. Stimulus-responsive nanopreparations for tumor targeting. Integr Biol 2013, 5:96–107.
2. Perche F, Torchilin VP. Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J Drug Deliv 2013, 2013:705265.
3. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013, 8:102.
4. Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 2009, 71:431–444.
5. Barenholz Y. Doxil®—The first FDA-approved nano-drug: Lessons learned. J Control Release 2012, 160:117–134.
6. Felber AE, Dufresne M-H, Leroux J-C. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 2012, 64:979–992.
7. Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, MacRobert AJ. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release 2012, 157:196–205.
8. Thamphiwatana S, Fu V, Zhu J, Lu D, Gao W, Zhang L. Nanoparticle-stabilized liposomes for pH-responsive gastric drug delivery. Langmuir 2013, 29:12228–12233.
9. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47:113–131.
10. Srivastava S, Tirrell MV. Polyelectrolyte complexation. In: Rice SA, Dinner AR, eds. Advances in Chemical Physics. Hoboken, NJ: John Wiley & Sons, Inc.; 2016, 499–544.
11. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf, B 2010, 75:1–18.
12. Trivedi R, Kompella UB. Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine (Lond) 2010, 5:485–505.
13. Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 2010, 6:714–729.
14. Rolland J, Guillet P, Schumers JM, Duhem N, Preat V, Gohy JF. Polyelectrolyte complex nanoparticles from chitosan and poly(acrylic acid) and polystyrene-block-poly(acrylic acid). J Polym Sci, Part A: Polym Chem 2012, 50:4484–4493.
15. Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC. Polymeric nanoparticles for drug delivery. In: Grobmyer SR, Moudgil BM, eds. Cancer Nanotechnology: Methods and Protocols. Totowa, NJ: Humana Press; 2010, 163–175.
16. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001, 70:1–20.
17. Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 2012, 64:866–884.
18. Zhang H, Li R-Y, Lu X, Mou Z-Z, Lin G-M. Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution. J Zhejiang Univ Sci B 2012, 13:981–989.
19. Soares DCF, de Oliveira MC, Gouvea dos Santos R, Andrade MS, Vilela JMC, Cardoso VN, Ramaldes GA. Liposomes radiolabeled with 159Gd-DTPA-BMA: Preparation, physicochemical characterization, release profile and in vitro cytotoxic evaluation. Eur J Pharm Sci 2011, 42:462–469.
20. Ghanbarzadeh S, Arami S, Pourmoazzen Z, Khorrami A. Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes. Colloids Surf, B 2014, 115:323–330.
21. Kono K, Kaiden T, Yuba E, Sakanishi Y, Harada A. Synthesis of oligo(ethylene glycol)-modified hyperbranched poly(glycidol)s for dual sensitization of liposomes to pH and temperature. J Taiwan Inst Chem Eng 2014, 45:3054–3061.
22. Massey JB. Effect of cholesteryl hemisuccinate on the interfacial properties of phosphatidylcholine bilayers. Biochim Biophys Acta 1998, 1415:193–204.
23. Xu H, Hu M, Yu X, Li Y, Fu Y, Zhou X, Zhang D, Li J. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery. Eur J Pharm Biopharm 2015, 91:66–74.
24. Barbosa MV, Monteiro LOF, Carneiro G, Malagutti AR, Vilela JMC, Andrade MS, Oliveira MC, Carvalho-Junior AD, Leite EA. Experimental design of a liposomal lipid system: a potential strategy for paclitaxel-based breast cancer treatment. Colloids Surf, B 2015, 136:553–561.
25. Hu Y, Zhao Z, Ehrich M, Fuhrman K, Zhang C. In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles. Polymer 2015, 80:171–179.
26. Chang M, Lu S, Zhang F, Zuo T, Guan Y, Wei T, Shao W, Lin G. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting. Colloids Surf, B 2015, 129:175–182.
27. Paliwal SR, Paliwal R, Agrawal GP, Vyas SP. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin. J. Liposome Res 2016, 26:276–287.
28. Xu H, Paxton JW, Wu Z. Enhanced pH-responsiveness, cellular trafficking, cytotoxicity and long-circulation of PEGylated liposomes with post-insertion technique using gemcitabine as a model drug. Pharm Res 2015, 32:2428–2438.
29. Torres E, Mainini F, Napolitano R, Fedeli F, Cavalli R, Aime S, Terreno E. Improved paramagnetic liposomes for MRI visualization of pH triggered release. J Control Release 2011, 154:196–202.
30. Castelli DD, Boffa C, Giustetto P, Terreno E, Aime S. Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultrasound stimulation. J Biol Inorg Chem 2014, 19:207–214.
31. Lee S-M, Lee O-S, O'Halloran TV, Schatz GC, Nguyen ST. Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study. ACS Nano 2011, 5:3961–3969.
32. Jelezova I, Drakalska E, Momekova D, Shalimova N, Momekov G, Konstantinov S, Rangelov S, Pispas S. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems. Eur J Pharm Sci 2015, 78:67–78.
33. Huang Y-F, Chiang W-H, Tsai P-L, Chern C-S, Chiu H-C. Novel hybrid vesicles co-assembled from a cationic lipid and PAAc-g-mPEG with pH-triggered transmembrane channels for controlled drug release. Chem Commun 2011, 47:10978–10980.
34. Wang Y, Tu S, Pinchuk AN, Xiong MP. Active drug encapsulation and release kinetics from hydrogel-in-liposome nanoparticles. J Colloid Interface Sci 2013, 406:247–255.
35. Popescu M-T, Mourtas S, Pampalakis G, Antimisiaris SG, Tsitsilianis C. pH-responsive hydrogel/liposome soft nanocomposites for tuning drug release. Biomacromolecules 2011, 12:3023–3030.
36. Sevimli S, Inci F, Zareie HM, Bulmus V. Well-defined cholesterol polymers with pH-controlled membrane switching activity. Biomacromolecules 2012, 13:3064–3075.
37. Zhou W, An X, Wang J, Shen W, Chen Z, Wang X. Characteristics, phase behavior and control release for copolymer-liposome with both pH and temperature sensitivities. Colloids Surf, A 2012, 395:225–232.
38. Alves P, Hugo AA, Szymanowski F, Tymczyszyn EE, Gomez-Zavaglia A, Perez PF, Coelho JFJ, Simoes PN. Stabilization of polymer lipid complexes prepared with lipids of lactic acid bacteria upon preservation and internalization into eukaryotic cells. Colloids Surf, B 2014, 123:446–451.
39. Barea MJ, Jenkins MJ, Lee YS, Johnson P, Bridson RH. Encapsulation of liposomes within pH responsive microspheres for oral colonic drug delivery. Int J Biomater 2012, 2012:458712–458718.
40. Lu T, Wang Z, Ma Y, Zhang Y, Chen T. Influence of polymer size, liposomal composition, surface charge, and temperature on the permeability of pH-sensitive liposomes containing lipid-anchored poly(2-ethylacrylic acid). Int J Nanomed 2012, 7:4917–4926.
41. Meng F, Zhong Z. Polymersomes spanning from nano- to microscales: advanced vehicles for controlled drug delivery and robust vesicles for virus and cell mimicking. J Phys Chem Lett 2011, 2:1533–1539.
42. Du Y, Chen W, Zheng M, Meng F, Zhong Z. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride. Biomaterials 2012, 33:7291–7299.
43. Chen P, Qiu M, Deng C, Meng F, Zhang J, Cheng R, Zhong Z. pH-responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(L-leucine)-b-poly(L-glutamic acid) triblock opolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride. Biomacromolecules 2015, 16:1322–1330.
44. Wang L, Geng D, Su H. Safe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicity. Colloids Surf, B 2014, 123:395–402.
45. Yoshizaki Y, Yuba E, Sakaguchi N, Koiwai K, Harada A, Kono K. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy. Biomaterials 2014, 35:8186–8196.
46. Yuba E, Kanda Y, Yoshizaki Y, Teranishi R, Harada A, Sugiura K, Izawa T, Yamate J, Sakaguchi N, Koiwai K, et al. pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy. Biomaterials 2015, 67:214–224.
47. Li Y, Liu R, Yang J, Shi Y, Ma G, Zhang Z, Zhang X. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials 2015, 41:1–14.
48. Li Y, Liu R, Yang J, Ma G, Zhang Z, Zhang X. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy. Biomaterials 2014, 35:9731–9745.
49. Liu Y, Gao F-P, Zhang D, Fan Y-S, Chen X-G, Wang H. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems. J Control Release 2014, 173:140–147.
50. Hao W, Han X, Shang Y, Xu S, Liu H. Insertion of pH-sensitive bola-type copolymer into liposome as a "stability anchor" for control of drug release. Colloids Surf, B 2015, 136:809–816.
51. Guo P, You J-O, Yang J, Jia D, Moses MA, Auguste DT. Inhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockade. Mol Pharm 2014, 11:755–765.
52. Chiang Y-T, Lo C-L. pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy. Biomaterials 2014, 35:5414–5424.
53. Moku G, Gulla SK, Nimmu NV, Khalid S, Chaudhuri A. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes. Biomater Sci 2016, 4:627–638.
54. Jiang L, Li L, He X, Yi Q, He B, Cao J, Pan W, Gu Z. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials 2015, 52:126–139.
55. Sanchez M, Aranda FJ, Teruel JA, Ortiz A. New pH-sensitive liposomes containing phosphatidylethanolamine and a bacterial dirhamnolipid. Chem Phys Lipids 2011, 164:16–23.
56. Huang W, Zhang J, Dorn HC, Zhang C. Assembly of bio-nanoparticles for double controlled drug release. PLoS One 2013, 8:e74679.
57. Alam MI, Paget T, Elkordy AA. Formulation and advantages of furazolidone in liposomal drug delivery systems. Eur J Pharm Sci 2016, 84:139–145.
58. Caddeo C, Diez-Sales O, Pons R, Carbone C, Ennas G, Puglisi G, Fadda AM, Manconi M. Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin. J Colloid Interface Sci 2016, 461:69–78.
59. Yan L, Crayton SH, Thawani JP, Amirshaghaghi A, Tsourkas A, Cheng Z. A pH-responsive drug-delivery platform based on glycol chitosan-coated liposomes. Small 2015, 11:4870–4874.
60. Yao Y, Su Z, Liang Y, Zhang N. pH-sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery. Int J Nanomedicine 2015, 10:6185–6197.
61. Mo R, Sun Q, Xue J, Li N, Li W, Zhang C, Ping Q. Multistage pH-responsive iposomes for mitochondrial-targeted anticancer drug delivery. Adv Mater 2012, 24:3659–3665.
62. Mo R, Sun Q, Li N, Zhang C. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Biomaterials 2013, 34:2773–2786.
63. Xu X, Zhang L, Assanhou AG, Wang L, Zhang Y, Li W, Xue L, Mo R, Zhang C. Acid/redox dual-activated liposomes for tumor-targeted drug delivery and enhanced therapeutic efficacy. RSC Adv 2015, 5:67803–67808.
64. Zhao Y, Ren W, Zhong T, Zhang S, Huang D, Guo Y, Yao X, Wang C, Zhang W-Q, Zhang X, et al. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. J Control Release 2016, 222:56–66.
65. Shi K, Long Y, Xu C, Wang Y, Qiu Y, Yu Q, Liu Y, Zhang Q, Gao H, Zhang Z, et al. Liposomes combined an integrin αvβ3-specific vector with pH-responsible cell-penetrating property for highly effective antiglioma therapy through the blood–brain barrier. ACS Appl Mater Interfaces 2015, 7:21442–21454.
66. Shi K, Li J, Cao Z, Yang P, Qiu Y, Yang B, Wang Y, Long Y, Liu Y, Zhang Q, et al. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. J Control Release 2015, 217:138–150.
67. Burks SR, Legenzov EA, Martin EW, Li C, Lu W, Kao JPY. Co-encapsulating the fusogenic peptide INF7 and molecular imaging probes in liposomes increases intracellular signal and probe retention. PLoS One 2015, 10:e0120982.
68. Su C, Xia Y, Sun J, Wang N, Zhu L, Chen T, Huang Y, Liang D. Liposomes physically coated with peptides: preparation and characterization. Langmuir 2014, 30:6219–6227.
69. Gopi HN, Reja RM, Khan M, Singh SK, Misra R, Shiras A. pH sensitive coiled coils : a strategy for enhanced liposomal drug delivery. Nanoscale 2016, 8:5139–5145.
70. Bandekar A, Karve S, Chang M-Y, Mu Q, Rotolo J, Sofou S. Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin. Biomaterials 2012, 33:4345–4352.
71. Sun T, Li Y, Zhang H, Li J, Xin F, Kong L, Hao A. pH-reversible vesicles based on the "supramolecular amphiphilies" formed by cyclodextrin and anthraquinone derivate. Colloids Surf, A 2011, 375:87–96.
72. Samoshina NM, Liu X, Brazdova B, Franz AH, Samoshin VV, Guo X. Fliposomes: pH-sensitive liposomes containing a trans-2-morpholinocyclohexanol-based lipid that performs a conformational flip and triggers an instant cargo release in acidic medium. Pharmaceutics 2011, 3:379–405.
73. Samoshin AV, Veselov IS, Chertkov VA, Yaroslavov AA, Grishina GV, Samoshina NM, Samoshin VV. Fliposomes: new amphiphiles based on trans-3,4-bis(acyloxy)-piperidine able to perform a pH-triggered conformational flip and cause an instant cargo release from liposomes. Tetrahedron Lett 2013, 54:5600–5604.
74. Zheng Y, Liu X, Samoshina NM, Samoshin VV, Franz AH, Guo X. Trans-2-aminocyclohexanol-based amphiphiles as highly efficient helper lipids for gene delivery by lipoplexes. Biochim Biophys Acta Biomembr 2015, 1848:3113–3125.
75. Viricel W, Mbarek A, Leblond J. Switchable lipids: Conformational change for fast pH-triggered cytoplasmic delivery. Angew Chem Int Ed 2015, 54:12743–12747.
76. Xia GM, An ZJ, Wang Y, Zhao C, Li M, Li ZC, Ma J. Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome. Chem Pharm Bull 2013, 61:390–398.
77. Li J, Zhou Y, Li C, Wang D, Gao Y, Zhang C, Zhao L, Li Y, Liu Y, Li X. Poly(2-ethyl-2-oxazoline)–doxorubicin conjugate-based dual endosomal pH-sensitive micelles with enhanced antitumor efficacy. Bioconjug Chem 2015, 26:110–119.
78. Xu H, Zhang W, Li Y, Ye FF, Yin PP, Yu X, Hu MN, Fu YS, Wang C, Shang DJ. The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape. Pharm Res 2014, 31:3038–3050.
79. Zanta MA, Belguise-Valladier P, Behr J-P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999, 96:91–96.
80. Xu Y, Szoka FC. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996, 35:5616–5623.
81. Hong BJ, Chipre AJ, Nguyen ST. Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNA. J Am Chem Soc 2013, 135:17655–17658.
82. Chen H, Zhang H, Thor D, Rahimian R, Guo X. Novel pH-sensitive cationic lipids with linear ortho ester linkers for gene delivery. Eur J Med Chem 2012, 52:159–172.
83. Shin J, Shum P, Grey J, Fujiwara S-I, Malhotra GS, Gonzalez-Bonet A, Hyun S-H, Moase E, Allen TM, Thompson DH. Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics. Mol Pharm 2012, 9:3266–3276.
84. Kim H-K, Van den Bossche J, Hyun S-H, Thompson DH. Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity. Bioconjug Chem 2012, 23:2071–2077.
85. Koren E, Apte A, Jani A, Torchilin VP. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. J Control Release 2012, 160:264–273.
86. Ding Y, Sun D, Wang G-L, Yang H-G, Xu H-F, Chen J-H, Xie Y, Wang Z-Q. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery. Int J Nanomedicine 2015, 10:6199–6214.
87. Chen D, Sun K, Mu H, Tang M, Liang R, Wang A, Zhou S, Sun H, Zhao F, Yao J, et al. pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system. Int J Nanomed 2012, 7:2621–2630.
88. Kolli S, Wong S-P, Harbottle R, Johnston B, Thanou M, Miller AD. pH-triggered nanoparticle mediated delivery of siRNA to liver cells in vitro and in vivo. Bioconjug Chem 2013, 24:314–332.
89. 2gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells. Chem Commun 2012, 48:4869–4871.
90. Hatakeyama H, Murata M, Sato Y, Takahashi M, Minakawa N, Matsuda A, Harashima H. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice. J Control Release 2014, 173:43–50.
91. Hada T, Sakurai Y, Harashima H. Optimization of a siRNA carrier modified with a pH-sensitive cationic lipid and a cyclic RGD peptide for efficiently targeting tumor endothelial cells. Pharmaceutics 2015, 7:320–333.
92. Fugit KD, Anderson BD. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan. J Control Release 2014, 174:88–97.
93. Bersani S, Vila-Caballer M, Brazzale C, Barattin M, Salmaso S. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells. Eur J Pharm Biopharm 2014, 88:670–682.
94. Pacheco-Torres J, Lopez-Larrubia P, Cerdan S, Mukherjee N, Walko M, Ballesteros P, Kocer A. Image guided drug release from pH-sensitive Ion channel-functionalized stealth liposomes into an in vivo glioblastoma model. Nanomedicine 2015, 11:1345–1354.
95. Chen Q, Ding H, Zhou J, Zhao X, Zhang J, Yang C, Li K, Qiao M, Hu H, Ding P, et al. Novel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activities. RSC Adv 2016, 6:17782–17791.
96. Liu Z, Tang S, Xu Z, Wang Y, Zhu X, Li L-C, Hong W, Wang X. Preparation and in vitro evaluation of a multifunctional iron silicate@liposome nanohybrid for pH-sensitive doxorubicin delivery and photoacoustic imaging. J Nanomater 2015, 2015:541763/541761–541763/541714.
97. Tripathy N, Ahmad R, Ko HA, Khang G, Hahn Y-B. Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system. Nanoscale 2015, 7:4088–4096.
98. Murata K, Egami H, Kiyohara H, Oshima S, Kurizaki T, Ogawa M. Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. Br J Cancer 1993, 68:103–111.
99. Arouri A, Mouritsen OG. Phospholipase A2-susceptible liposomes of anticancer double lipid-prodrugs. Eur J Pharm Sci 2012, 45:408–420.
100. Linderoth L, Peters GH, Madsen R, Andresen TL. Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties. Angew Chem Int Ed 2009, 48:1823–1826.
101. Kaasgaard T, Andresen TL, Jensen SS, Holte RO, Jensen LT, Jorgensen K. Liposomes containing alkylated methotrexate analogues for phospholipase A2 mediated tumor targeted drug delivery. Chem Phys Lipids 2009, 157:94–103.
102. Linderoth L, Fristrup P, Hansen M, Melander F, Madsen R, Andresen TL, Peters GH. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid. J Am Chem Soc 2009, 131:12193–12200.
103. Arouri A, Hansen AH, Rasmussen TE, Mouritsen OG. Lipases, liposomes and lipid-prodrugs. Curr Opin Colloid Interface Sci 2013, 18:419–431.
104. Pedersen PJ, Adolph SK, Subramanian AK, Arouri A, Andresen TL, Mouritsen OG, Madsen R, Madsen MW, Peters GH, Clausen MH. Liposomal formulation of retinoids designed for enzyme triggered release. J Med Chem 2010, 53:3782–3792.
105. Hansen AH, Mouritsen OG, Arouri A. Enzymatic action of phospholipase A2 on liposomal drug delivery systems. Int J Pharm 2015, 491:49–57.
106. Zhu G-D, Alhamhoom Y, Cummings BS, Arnold RD. Synthesis of lipids for development of multifunctional lipid-based drug carriers. Bioorg Med Chem Lett 2011, 21:6370–6375.
107. Xing H, Zhang CL, Ruan G, Zhang J, Hwang K, Lu Y. Multimodal detection of a small molecule target using stimuli-responsive liposome triggered by aptamer-enzyme conjugate. Anal Chem 2016, 88:1506–1510.
108. Thamphiwatana S, Gao W, Pornpattananangkul D, Zhang Q, Fu V, Li J, Li J, Obonyo M, Zhang L. Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Mater Chem B 2014, 2:8201–8207.
109. Ferguson EL, De Luca E, Heenan RK, King SM, Griffiths PC. Time-resolved small-angle neutron scattering as a tool for studying controlled release from liposomes using polymer-enzyme conjugates. Macromol Rapid Commun 2010, 31:1685–1690.
110. 2+elease from diplasmenylcholine liposomes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes. Bioconjug Chem 1998, 9:305–308.
111. Shimanouchi T, Kawasaki H, Fuse M, Umakoshi H, Kuboi R. Membrane fusion mediated by phospholipase C under endosomal pH conditions. Colloids Surf, B 2013, 103:75–83.
112. Wan Y, Han J, Fan G, Zhang Z, Gong T, Sun X. Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity. Biomaterials 2013, 34:3020–3030.
113. Banerjee J, Hanson AJ, Gadam B, Elegbede AI, Tobwala S, Ganguly B, Wagh AV, Muhonen WW, Law B, Shabb JB, et al. Release of liposomal contents by cell-secreted matrix metalloproteinase-9. Bioconjug Chem 2009, 20:1332–1339.
114. Kulkarni PS, Haldar MK, Nahire RR, Katti P, Ambre AH, Muhonen WW, Shabb JB, Padi SKR, Singh RK, Borowicz PP, et al. MMP-9 responsive PEG cleavable nanovesicles for efficient elivery of chemotherapeutics to pancreatic cancer. Mol Pharm 2014, 11:2390–2399.
115. Xu P, Meng Q, Sun H, Yin Q, Yu H, Zhang Z, Cao M, Zhang Y, Li Y. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer. Biomaterials 2015, 64:10–20.
116. Yingyuad P, Mevel M, Prata C, Kontogiorgis C, Thanou M, Miller AD. Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA. J RNAi Gene Silencing 2014, 10:490–499.
117. Yingyuad P, Mevel M, Prata C, Furegati S, Kontogiorgis C, Thanou M, Miller AD. Enzyme-triggered PEGylated pDNA-nanoparticles for controlled release of pDNA in tumors. Bioconjug Chem 2013, 24:343–362.
118. Koren E, Apte A, Sawant RR, Grunwald J, Torchilin VP. Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements. Drug Deliv 2011, 18:377–384.
119. Song SJ, Lee S, Lee Y, Choi JS. Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery. Eur J Pharm Sci 2016, 91:20–30.
120. Wang Y, Zhang L, Guo S, Hatefi A, Huang L. Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery. J Control Release 2013, 172:179–189.
121. Jo S-M, Lee H-Y, Kim J-C. Glucose-sensitivity of liposomes incorporating conjugates of glucose oxidase and poly(N-isopropylacrylamide-co-methacrylic acid-co-octadecylacrylate). Int J Biol Macromol 2009, 45:421–426.
122. Hong YJ, Lee HY, Kim J-C. Alginate beads containing pH-sensitive liposomes and glucose oxidase: glucose-sensitive release. Colloid Polym Sci 2009, 287:1207–1214.
123. Jo S-M, Kim J-C. Glucose-triggered release from liposomes incorporating poly(N-isopropylacrylamide-co-methacrylic acid-co-octadecylacrylate) and glucose oxidase. Colloid Polym Sci 2009, 287:379–384.
124. Jang WS, Park SC, Reed EH, Dooley KP, Wheeler SF, Lee D, Hammer DA. Enzymatically triggered rupture of polymersomes. Soft Matter 2016, 12:1014–1020.
125. Chandrawati R, Odermatt PD, Chong S-F, Price AD, Stadler B, Caruso F. Triggered cargo release by encapsulated enzymatic catalysis in capsosomes. Nano Lett 2011, 11:4958–4963.
126. Grinberg S, Kipnis N, Linder C, Kolot V, Heldman E. Asymmetric bolaamphiphiles from vernonia oil designed for drug delivery. Eur J Lipid Sci Technol 2009, 112:137–151.
127. Ye T, Jiang X, Li J, Yang R, Mao Y, Li K, Li L, Chen F, Yao J, Wu Y, et al. Low molecular weight heparin mediating targeting of lymph node metastasis based on nanoliposome and enzyme-substrate interaction. Carbohydr Polym 2015, 122:26–38.
128. McCarley RL. Redox-responsive delivery systems. Annu Rev Anal Chem 2012, 5:391–411.
129. Candiani G, Pezzoli D, Ciani L, Chiesa R, Ristori S. Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action. PLoS One 2010, 5:e13430.
130. Fu H, Shi K, Hu G, Yang Y, Kuang Q, Lu L, Zhang L, Chen W, Dong M, Chen Y, et al. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol). J Pharm Sci 2015, 104:1160–1173.
131. Zhang S, Zhao Y. Controlled release from cleavable polymerized liposomes upon redox and pH stimulation. Bioconjug Chem 2011, 22:523–528.
132. Sun Q, Kang Z, Xue L, Shang Y, Su Z, Sun H, Ping Q, Mo R, Zhang C. A collaborative assembly strategy for tumor-targeted siRNA delivery. J Am Chem Soc 2015, 137:6000–6010.
133. Loew M, Forsythe JC, McCarley RL. Lipid nature and their influence on opening of redox-active liposomes. Langmuir 2013, 29:6615–6623.
134. McCarley RL, Forsythe JC, Loew M, Mendoza MF, Hollabaugh NM, Winter JE. Release rates of liposomal contents are controlled by kosmotropes and chaotropes. Langmuir 2013, 29:13991–13995.
135. Mendoza MF, Hollabaugh NM, Hettiarachchi SU, McCarley RL. Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups. Biochemistry 2012, 51:8014–8026.
136. Aytar BS, Muller JPE, Golan S, Kondo Y, Talmon Y, Abbott NL, Lynn DM. Chemical oxidation of a redox-active, ferrocene-containing cationic lipid: Influence on interactions with DNA and characterization in the context of cell transfection. J Colloid Interface Sci 2012, 387:56–64.
137. Kumar K, Vulugundam G, Kondaiah P, Bhattacharya S. Co-liposomes of redox-active alkyl-ferrocene modified low MW branched PEI and DOPE for efficacious gene delivery in serum. J Mater Chem B 2015, 3:2318–2330.
138. Vulugundam G, Kumar K, Kondaiah P, Bhattacharya S. Efficacious redox-responsive gene delivery in serum by ferrocenylated monomeric and dimeric cationic cholesterols. Org Biomol Chem 2015, 13:4310–4320.
139. Conceição D, Ferreira D, Ferreira L. Photochemistry and cytotoxicity evaluation of heptamethinecyanine near infrared (NIR) dyes. Int J Mol Sci 2013, 14:18557.
140. Yavlovich A, Smith B, Gupta K, Blumenthal R, Puri A. Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications. Mol Membr Biol 2010, 27:364–381.
141. Leung SJ, Romanowski M. Light-activated content release from liposomes. Theranostics 2012, 2:1020–1036.
142. Yavlovich A, Singh A, Tarasov S, Capala J, Blumenthal R, Puri A. Design of liposomes containing photopolymerizable phospholipids for triggered release of contents. J Therm Anal Calorim 2009, 98:97–104.
143. Yavlovich A, Singh A, Blumenthal R, Puri A. A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubicin to cells. Biochim Biophys Acta Biomembr 2011, 1808:117–126.
144. Guo C, Liu S, Jiang C, Li W, Dai Z, Fritz H, Wu X. A promising drug controlled-release system based on diacetylene/phospholipid polymerized vesicles. Langmuir 2009, 25:13114–13119.
145. Sine J, Urban C, Thayer D, Charron H, Valim N, Tata DB, Schiff R, Blumenthal R, Joshi A, Puri A. Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. Int J Nanomed 2015, 10:125–145.
146. Luo D, Carter KA, Razi A, Geng J, Shao S, Giraldo D, Sunar U, Ortega J, Lovell JF. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials 2016, 75:193–202.
147. Carter KA, Wang S, Geng J, Luo D, Shao S, Lovell JF. Metal chelation modulates phototherapeutic properties of mitoxantrone-loaded porphyrin-phospholipid liposomes. Mol Pharm 2016, 13:420–427.
148. Mahmoud G, Jedelska J, Strehlow B, Bakowsky U. Bipolar tetraether lipids derived from thermoacidophilic archaeon sulfolobus acidocaldarius for membrane stabilization of chlorin e6 based liposomes for photodynamic therapy. Eur J Pharm Biopharm 2015, 95:88–98.
149. Peng P-C, Hong R-L, Tsai Y-J, Li P-T, Tsai T, Chen C-T. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment. Lasers Surg Med 2015, 47:77–87.
150. Reshetov V, Lassalle H-P, Francois A, Dumas D, Hupont S, Graefe S, Filipe V, Jiskoot W, Guillemin F, Zorin V, et al. Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo. Int J Nanomed 2012, 8:3817–3831.
151. Garrier J, Reshetov V, Graefe S, Guillemin F, Zorin V, Bezdetnaya L. Factors affecting the selectivity of nanoparticle-based photoinduced damage in free and xenografted chorioallantoic membrane model. J Drug Target 2014, 22:220–231.
152. Randles EG, Bergethon PR. A photodependent switch of liposome stability and permeability. Langmuir 2013, 29:1490–1497.
153. Pashkovskaya A, Kotova E, Zorlu Y, Dumoulin F, Ahsen V, Agapov I, Antonenko Y. Light-triggered liposomal release: membrane permeabilization by photodynamic action. Langmuir 2010, 26:5726–5733.
154. Aygun A, Torrey K, Kumar A, Stephenson LD. Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes. Appl Biochem Biotechnol 2012, 167:743–757.
155. Rwei AY, Lee J-J, Zhan C, Liu Q, Ok MT, Shankarappa SA, Langer R, Kohane DS. Repeatable and adjustable on-demand sciatic nerve block with phototriggerable liposomes. Proc Natl Acad Sci USA 2015, 112:15719–15724.
156. Kozikowski RT, Sorg BS. Delayed photolysis of liposomes: a strategy for the precision timing of bolus drug release using ex-vivo photochemical sensitization. Proc SPIE 2012, 8221:82211I/82211–82211I/82218.
157. Teng IT, Chang Y-J, Wang L-S, Lu H-Y, Wu L-C, Yang C-M, Chiu C-C, Yang C-H, Hsu S-L, Ho J-aA. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer. Biomaterials 2013, 34:7462–7470.
158. Tachikawa S, Sato S, Hazama H, Awazu K, Kaneda Y, Nakamura H. Localization-dependent cell-killing effects of protoporphyrin (PPIX)-lipid micelles and liposomes in photodynamic therapy. Bioorg Med Chem 2015, 23:7578–7584.
159. Araki T, Ogawara K-I, Suzuki H, Kawai R, Watanabe T-I, Ono T, Higaki K. Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature. J Control Release 2015, 200:106–114.
160. Basoglu H, Bilgin MD, Demir MM. Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: Fabrication, characterization and in vitro study. Photodiagnosis Photodyn Ther 2016, 13:81–90.
161. Mir Y, Elrington SA, Hasan T. A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer. Nanomedicine 2013, 9:1114–1122.
162. Tangutoori S, Spring BQ, Mai Z, Palanisami A, Mensah LB, Hasan T. Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer. Nanomedicine 2016, 12:223–234.
163. Spring BQ, Bryan Sears R, Zheng LZ, Mai Z, Watanabe R, Sherwood ME, Schoenfeld DA, Pogue BW, Pereira SP, Villa E, et al. A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways. Nat Nanotechnol 2016, 11:378–387.
164. Fang N-C, Cheng F-Y, Ho J-AA, Yeh C-S. Photocontrolled targeted drug delivery: photocaged biologically active folic cid as a light-responsive tumor-targeting molecule. Angew Chem Int Ed 2012, 51:S8806/8801–S8806/8817.
165. Yang Y, Yang Y, Xie X, Wang Z, Gong W, Zhang H, Li Y, Yu F, Li Z, Mei X. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials 2015, 48:84–96.
166. Xie XY, Yang YF, Yang Y, Mei XG. Photolabile-caged peptide-conjugated liposomes for siRNA delivery. J Drug Target 2015, 23:789–799.
167. Lin W, Xie X, Yang Y, Liu H, Fu X, Chen Y, Liu H, Yang Y. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands. J Pharm Pharmacol 2015, 67:1215–1231.
168. Shemesh CS, Hardy CW, Yu DS, Fernandez B, Zhang H. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells. Photodiagnosis Photodyn Ther 2014, 11:193–203.
169. Li M, Teh C, Ang CY, Tan SY, Luo Z, Qu Q, Zhang Y, Korzh V, Zhao Y. Near-infrared light-absorptive stealth liposomes for localized photothermal ablation of tumors combined with chemotherapy. Adv Funct Mater 2015, 25:5602–5610.
170. Guo F, Yu M, Wang J, Tan F, Li N. Smart IR780 theranostic nanocarrier for tumor-specific therapy: hyperthermia-mediated bubble-generating and folate-targeted liposomes. ACS Appl Mater Interfaces 2015, 7:20556–20567.
171. Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano 2013, 7:717–724.
172. Rengan AK, Jagtap M, De A, Banerjee R, Srivastava R. Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photothermal therapy of breast cancer cells. Nanoscale 2014, 6:916–923.
173. Wu C, Yu C, Chu M. A gold nanoshell with a silica inner shell synthesized using liposome templates for doxorubicin loading and near-infrared photothermal therapy. Int J Nanomed 2011, 6:807–813.
174. Wu G, Mikhailovsky A, Khant HA, Zasadzinski JA. Synthesis, characterization, and optical response of gold nanoshells used to trigger release from liposomes. Methods Enzymol 2009, 464:279–307.
175. Kojima C, Hirano Y, Kono K. Preparation of complexes of liposomes with gold nanoparticles. Methods Enzymol 2009, 464:131–145.
176. Forbes N, Zasadzinski JA. Photothermally activated drug release from liposomes coupled to hollow gold nanoshells. Proc SPIE 2011, 7911:79110P/79111–79110P/79112.
177. Mathiyazhakan M, Yang Y, Liu Y, Zhu C, Liu Q, Ohl C-D, Tam KC, Gao Y, Xu C. Non-invasive controlled release from gold nanoparticle integrated photo-responsive liposomes through pulse laser induced microbubble cavitation. Colloids Surf, B 2015, 126:569–574.
178. An X, Zhang F, Zhu Y, Shen W. Photoinduced drug release from thermosensitive AuNPs-liposome using a AuNPs-switch. Chem Commun (Camb) 2010, 46:7202–7204.
179. Li J, An X, Pan Z, Sun L. Photoinduced drug release from complexes of liposome and fluorescent silver nanoparticles. RSC Adv 2014, 4:9476–9479.
180. Kwon HJ, Byeon Y, Jeon HN, Cho SH, Han HD, Shin BC. Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect. J Control Release 2015, 216:132–139.
181. Zhan C, Wang W, McAlvin JB, Guo S, Timko BP, Santamaria C, Kohane DS. Phototriggered local anesthesia. Nano Lett 2016, 16:177–181.
182. Guo H, Kim J-C. Photothermally induced release from liposome suspended in mixture solution of gold nanoparticle and thermo-sensitive polymer. Colloids Surf, A 2015, 469:73–82.
183. You J, Zhang P, Hu F, Du Y, Yuan H, Zhu J, Wang Z, Zhou J, Li C. Near-infrared light-Sesnsitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy. Pharm Res 2014, 31:554–565.
184. Li Q, Tang Q, Zhang P, Wang Z, Zhao T, Zhou J, Li H, Ding Q, Li W, Hu F, et al. Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes. Biomaterials 2015, 57:1–11.
185. Seo HJ, Kim J-C. 7-Acetoxycoumarin dimer-incorporated and folate-decorated liposomes: photoresponsive release and in vitro targeting and efficacy. Bioconjug Chem 2014, 25:533–542.
186. Ostrowski AD, Lin BF, Tirrell MV, Ford PC. Liposome encapsulation of a photochemical NO precursor for controlled nitric oxide release and simultaneous fluorescence imaging. Mol Pharm 2012, 9:2950–2955.
187. Hester TJ, Dennison SR, Baker MJ, Snape TJ. Functionalising the azobenzene motif delivers a light-responsive membrane-interactive compound with the potential for photodynamic therapy applications. Org Biomol Chem 2015, 13:8067–8070.
188. Meerovich I, Muthukrishnan N, Johnson GA, Erazo-Oliveras A, Pellois J-P. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide. Biochim Biophys Acta 2014, 1840:507–515.
189. Wang H, Liu Z, Wang S, Dong C, Gong X, Zhao P, Chang J. MC540 and upconverting nanocrystal coloaded polymeric liposome for near-infrared light-triggered photodynamic therapy and cell fluorescent imaging. ACS Appl Mater Interfaces 2014, 6:3219–3225.
190. Huang H-L, Lu P-H, Yang H-C, Li H-R, Liao K-C, Lee G-D. Fiber-optic triggered release of liposome in vivo: Implication of personalized chemotherapy. Int J Nanomedicine 2015, 10:5171–5184.
191. Wang X, Debefve E, Ris H-B, Perentes JY, Gronchi F, Bensimon M, Wagnieres G, Mercier T, Decosterd LA, Letovanec I, et al. Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: proof of concept on rodent lung tumors and feasibility study on porcine chest cavities. Lasers Surg Med 2015, 47:807–816.
192. Arai S, Lee C-LK, Chang Y-T, Sato H, Sou K. Thermosensitive nanoplatforms for photothermal release of cargo from liposomes under intracellular temperature monitoring. RSC Adv 2015, 5:93530–93538.
193. Narayanan T, Weerakkody D, Karabadzhak AG, Anderson M, Andreev OA, Reshetnyak YK. pHLIP peptide interaction with a membrane monitored by SAXS. J Phys Chem B 2016, 120:11484–11491.
194. Onyango JO, Chung MS, Eng C-H, Klees LM, Langenbacher R, Yao L, An M. Noncanonical amino acids to improve the pH response of pHLIP insertion at tumor acidity. Angew Chem Int Ed 2015, 127:3729–3734.
195. Yao L, Daniels J, Wijesinghe D, Andreev OA, Reshetnyak YK. pHLIP-mediated delivery of PEGylated liposomes to cancer cells. J Control Release 2013, 167:228–237.